Advancing Basal Insulin Therapy in Type 2 Diabetes: Individualizing Treatment in the Era of Once-Weekly Insulins
Published on November 1, 2026
Despite major advances in cardiometabolic therapies, many people with type 2 diabetes (T2D) will eventually require basal insulin. The clinical challenge is not only initiating insulin in appropriate patients but also optimizing therapy while avoiding overbasalization and minimizing treatment burden. Once-weekly basal insulins represent an important advancement that may help simplify insulin therapy for appropriate […]
The post Advancing Basal Insulin Therapy in Type 2 Diabetes: Individualizing Treatment in the Era of Once-Weekly Insulins appeared first on Endocrine News.